Chronic kidney disease in elderly: diagnostic and management challenges


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Epidemiology, risk factors, causes, clinical course and outcomes of chronic kidney disease in elderly population are discussed. Approaches to renal replacement therapy and conservative management are reviwed.

Full Text

Restricted Access

References

  1. Coresh J., Astor B. C., Greene T. et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey//Am. J. Kidney Dis. - 2003. - Vol. 41(1). - P. 1-12.
  2. Li S., Foley R.N., Collins A.J. et al. Anemia and cardiovascular disease, hospitalization, end stage renal disease, and death in older patients with chronic kidney disease// Int. Urol. Nephrol. - 2005. - Vol. 37. - P. 395-402.
  3. Тонелли М., Риелла М. Хроническая болезнь почек и старение популяции //Клин. нефрология. - 2014. - № 1. - С. 4-7.
  4. Stevens L.A., Viswanathan G., Weiner D.E. Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance // Adv Chronic Kidney Dis. - 2010. - Vol. 17(4). - P. 293-301.
  5. Stewens L.A., Li S., Wang C. et al. Prevalence of chronic kidney disease and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP) // Am J Kidney Dis. - 2010. - Vol. 55 (3 Suppl. 2). - P. S23-S33.
  6. Heras M., Fernandes-Reyres M.J., Sanchez R. et al. Elderly patients with chronic kidney disease: outcomes after 5 years of follow-up // Nefrologia. - 2012. - Vol. 32(3). - P. 300-305.
  7. Liu X., Ma H., Huang H. et al. Is the Chronic Kidney Disease Epidemiology Collaboration creatinine-cystatin C equation useful for glomerular filtration rate estimation in the elderly?// Clin Interv Aging. - 2013. - Vol. 8. - P. 1387-1391.
  8. Umemura T., Kawamura T., Umegaki H. et al. Association of chronic kidney disease and cerebral small vessel disease with cognitive impairment in elderly patients with type 2 diabetes//Dement Geriatr Cogn Dis Extra. - 2013. - Vol. 3(1). - P. 212-222.
  9. Cai G., Zheng Y., Sun X. et al: Survey of Prevalence, Awareness, and Treatment Rates in Chronic Kidney Disease Patients with Hypertension in China Collaborative Group. Prevalence, awareness, treatment, and control of hypertension in elderly adults with chronic kidney disease: results from the survey of Prevalence, Awareness, and Treatment Rates in Chronic Kidney Disease Patients with Hypertension in China // J Am Geriatr Soc. - 2013. - Vol. 61(12). - P. 2160-2167.
  10. Борисов И.А., Сура В.В., Попова Л.А. и др. К проблеме нефритов пожилого и старческого возраста // Тер. арх. - 1995. - № 6. - С. 5-9.
  11. Preston R.A., Stemmer C.L., Materson B.J. et al. Renal biopsy in patients 65 years of age or older. An analysis of the results of334 biopsies // J. Am. Geriatr. Soc. - 1990. - Vol. 38. - P. 669-674.
  12. Rychlik I., Jancova E., Tesar V. et al. The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994-2000 // Nephrol. Dial. Transplant. - 2004. - Vol. 19. - P. 3040-3049.
  13. Rivera F., Lopez-Gomez J.M., Perez-Garcia R. Clinicopathologic correlations of renal pathology in Spain // Kidney Int. - 2004. - Vol. 66. - P. 898-904
  14. Colombo V., Confalonieri R., Minola E. et al. Renal biopsies in the elderly // Contrib. Nephrol. - 1993. - Vol. 105. - P. 102-106.
  15. Cameron J.S. Nephrotic syndrome in the elderly // Semin. Nephrol. - Vol. 16. - P. 319-329.
  16. Lefaucheur C., Stengel B., Nochy D. et al.: GN-PROGRESS Study Group. Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association // Kidney Int. - 2006. - Vol. 70(8). - P. 1510-1517.
  17. Ohtani H., Wakui H., Komatsuda A. et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy // Nephrol. Dial. Transplant. - 2004. - Vol. 19(3). - P. 574-579.
  18. Мухин Н.А., Хасабов Н.Н., Невраева О.Г. Паранеопластическое поражение почек // Тер. арх. - 1986. - № 8. - С. 111-115.
  19. Козловская Л.В., Туганбекова С.К., Сейсембеков Т.З. Паранеопластическое поражение почек при солидных опухолях // Нефрология и диализ. - 2002. - №4(2). - С. 76-81.
  20. Donadio J.V. Treatment of glomerulonephritis in the elderly // Am. J. Kidney Dis. - 1990. - Vol. 16. - P. 307-311.
  21. Simon P., Ramee M.-P., Boulahrouz R. et al. Epidemilogic data of primary glomerular disease in western France // Kidney Int. - 2004. - Vol. 66. - P. 905-908.
  22. Washio M., Oh Y., Okuda S. et al. Clinicopathological study of poststreptococcal glomerulonephritis in the elderly // Clin. Nephrol. - 1994. - Vol. 41. - P. 265-270
  23. Борисов И.А., Сура В.В., Грибунов Ю.П. Пиелонефрит в старческом возрасте // Тер. архив. - 1983. - № 6. - С. 3-9.
  24. Ulinski T., Bensman A. Renal complications of non-steroidal antiinflammatories // Arch. Pediatr. - 2004. - Vol. 11. - P. 885-888.
  25. Noels I.M., Elseviers M.M., DeBroe M.E. Impact of legislative measures on the sales of analgetics and the subsequent prevalence of analgesic nephropathy: a comparative study in France, Sweden and Belgium // Nephrol. Dial. Transplant. - 1995. - Vol. 10. - P. 167-174.
  26. DeBroe M.E., Elseviers M.M., Bengtsson U. et al. Analgesic nephropathy // Nephrol. Dial. Transplant. - 1996. - Vol. 11. - P. 2407-2408.
  27. Henrich W.L. Analgesic nephropathy //Am. J. Kidney Dis. - 1996. - Vol. 28 (Suppl. 1). - P. S1-S70.
  28. Мухин Н.А. Снижение скорости клубочковой фильтрации - общепопуляционный маркер неблагоприятного прогноза // Тер. арх. - 2007. - № 6. - С. 5-10.
  29. Lao D., Parasher P.S., Cho K.C. et al. Atherosclerotic renal artery stenosis: diagnosis and treatment // Mayo Clin Proc. - 2011. - Vol. 86(7).- P. 649-657.
  30. Weber B.R., Dieter R.S. Reanl artery stenosis: epidemiology and treatment // Int J Nephrol Renovasc Dis. - 2014. - Vol. 7. - P. 169-181.
  31. Фомин В.В. Ишемическая болезнь почек: клинико-патогенетические особенности, диагностика, лечение // Клин. мед. - 2008. - № 86(4). - С. 8-14.
  32. Мухин Н.А., Фомин В.В., Моисеев С.В. и др. Ишемическая болезнь почек (атеросклеротическая реноваскулярная гипертензия): клинический вариант распространенного атеросклероза и причина хронической почечной недостаточности // Вестник РАМН. - 2008. - № 11. - С. 24-33.
  33. Caielli P., Frigo A.C., Pengo M.F. et al. Treatment of atherosclerotic renovascular hypertension: review of observational studies and a meta-analysis of randomized clinical trials // Nephrol Dial Transplant. - 2014 Apr 16 [Epub ahead of print].
  34. Cooper C.J., Murphy T.P., Cutlip D.E. et al.: CORAL Investigators. Stenting and medical therapy for atherosclerotic renal-artery stenosis // N Engl J Med. - 2014. - Vol. 370(1). - P. 13-22.
  35. Nitta K., Okada K., Yanai M. et al. Aging and chronic kidney disease//Kidney Blood Press Res. - 2013. - Vol. 38. - P. 109-120.
  36. Cooper B.A., Branley P., Bulfone L. et al.: IDEAL Study. A randomized controlled trial of early versus late initiation of dialysis // N Engl J Med. - 2010. - Vol. 363. - P. 609-619.
  37. Burns A., Davenport A. Maximum conservative management for patients with chronic kidney disease stage 5// Hemodial Int. - 2010. - Vol. 14. - P. S32- S37.
  38. Couchoud C., Dantony E., Elsensohn M.H. et al. Modelling treatment trajectories to optimize the organization of renal replacement therapy and public health decision-making// Nephrol Dial Transplant. - 2013. - Vol. 28(9). - P. 2372-2382.
  39. Berger J.R., Hedayati S.S. Renal replacement therapy in the elderly population // Clin J Am Soc Nephrol. - 2012. - Vol. 7. - P. 1039-1046.
  40. Laquaniti A., Bolignano D., Campo S. et al. Malnutrition in the elderly patient on dialysis // Ren Fail. - 2009. - Vol. 31. - P. 239-245.
  41. Kim J.C., Kalantar-Zadeh K., Kopple J.D. Frailty and protein-energy wasting in end-stage kidney disease // J Am Soc Nephrol. - 2013. - Vol. 24. - P. 337-351.
  42. Johansen K.L. Testosterone metabolism and replacement therapy in patients with end-stage renal disease // Semin Dial. - 2004. - Vol. 17. - P. 202-208.
  43. Kopple J.D., Cheung A.K., Christiansen J.K. et al.: OPPORTUNITY trial group. A large scale randomized clinical trial of growth hormone in hemodialysis patients // Nephrol Dial Transplant. - 2011. - Vol. 26. - P. 4095-4103.
  44. Giordano M., Ciarambino T., Castellino P. et al. Light and shadows of dietary protein restriction in elderly with chronic kidney diseas // Nutrition. - 2013. - Vol. 29(9). - P. 1090-1093.
  45. Brunori G., Viola B.F., Parrinello G. et al. Efficacy and safety of a very low-protein diet when postponing dialysis in elderly: a prospective randomized multicenter controlled study // Am J Kidney Dis. - 2007. - Vol. 49. - P. 569-580.
  46. Chauveau P., Couzi L., Vendrely B. et al. Long-term outcome on renal replacement therapy in patients who previously received a keto acid-supplement very-low-protein diet // Am J Clin Nutr. - 2009. - Vol. 90. - P. 969-974.
  47. Kovesdy Cs., Kopple J., Kalantar-Zadeh K. Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy// AJCN. First published ahead of print May 1, 2013 as doi: 10.3945/ajcn.112.036418.
  48. Scalone L., Borghetti F., Brunori G. et al. Cost-benefit analysis of supplemented very low-protein diet versus dialysis in elderly CKD5patients // Nephrol Dial Transplant. - 2010. Vol. 25. - P. 907-913.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies